A New Safety Approach Allowing Reversible Control of CAR T Cell Responses

Amanda XY Chen; Imran G House; Paul A Beavis; Phillip K Darcy

Journal article

A New Safety Approach Allowing Reversible Control of CAR T Cell Responses

Amanda XY Chen, Imran G House, Paul A Beavis, Phillip K Darcy

MOLECULAR THERAPY | CELL PRESS | Published : 2020

DOI: 10.1016/j.ymthe.2020.06.009

University of Melbourne Researchers

Phillip Darcy Author The Sir Peter Maccallum Department of Oncology

Paul Beavis Author The Sir Peter Maccallum Department of Oncology

Related Projects (2)

NEW STRATEGIES FOR ENHANCING CHIMERIC ANTIGEN RECEPTOR (CAR) T CELL THERAPY FOR CANCER

The role of the immune system in cancer is now recognised as highly important, highlighted by the success of immunotherapy in patients. Yet ..

IMMUNOBIOLOGY AND IMMUNOTHERAPY OF CANCER

For 60 years, we have had only 3 effective cancer treatments: surgery, radiation and chemotherapy, often used in combination.The last 5 year..

Grants

Awarded by National Health and Medical Research Council of Australia

Awarded by National Breast Cancer Foundation

Awarded by Cancer Council of Victoria

Awarded by National Breast Cancer Foundation Fellowship

Awarded by NHMRC Senior Research Fellowship

Funding Acknowledgements

The authors wish to acknowledge funding support from the National Health and Medical Research Council of Australia (APP1132373), the National Breast Cancer Foundation (IIRS-19-016 19-22), the Cancer Council of Victoria (APP1143517), and the CLEARbridge Foundation. A.X.Y.C. is supported by an Australian Government Research Training Program Scholarship and a Peter MacCallum Cancer Foundation Postgraduate Scholarship. P.A.B. is supported by a National Breast Cancer Foundation Fellowship (ID#ECF-17-005). P.K.D. is supported by an NHMRC Senior Research Fellowship (APP1136680).